Bilateral ankle oedema in a patient taking escitalopram

References

• American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington, DC: American Psychiatric Association.
   Google Scholar
• Baghai TC, Volz H-P, Möller H-J. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities. World J Biol Psychiatry 2006; 7: 198–222
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Cooper JA, Huusom AKT, Hindmarch I. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. Int Clin Psychopharmacol 2006; 21: 159–169
   PubMed Web of Science ®Google Scholar
• Biswas PN, Wilton LV, Shakir SAW. The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13554 patients in England. J Psychopharmacol 2003; 17: 121–126
   PubMed Web of Science ®Google Scholar
• Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarciapone. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. Curr Med Res Opin 2006; 22: 1331–1341
   PubMed Web of Science ®Google Scholar
• Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002; 63: 331–336
   PubMed Web of Science ®Google Scholar
• Cipralex, Prescribing information, http://www.cipralex.com/prescribing_information/default.aspx.
   Google Scholar
• Colonna L, Andersen HF, Reines EH. A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder. Curr Med Res Opin 2005; 21: 1659–1668
   PubMed Web of Science ®Google Scholar
• Culpepper LC. Escitalopram: A new SSRI for the treatment of depression in primary care. Primary Care Companion J Clin Psychiatry 2002; 4: 209–214
   PubMedGoogle Scholar
• Einarson TR. Evidence based review of escitalopram in treating major depressive disorder in primary care. Int Clin Psychopharmacol 2004; 19: 305–310
   PubMed Web of Science ®Google Scholar
• Kasper S, de Swart H, Andersen FH. Escitalopram in the treatment of depressed elderly patients. Am J Geriatr Psychiatry 2005; 13: 884–891
   PubMed Web of Science ®Google Scholar
• Krasowska D, Szymanek M, Schwartz RA, Myslinski W. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol 2006; 56: 848–853
   PubMed Web of Science ®Google Scholar
• Lepola UM, Loft H, Reines EH. Escitalopram (10–20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharmacol 2003; 18: 211–217
   PubMed Web of Science ®Google Scholar
• LoVecchio F, Watts D, Winchell J, Knight J, McDowell T. Outcomes after supratherapeutic escitalopram ingestions. J Emerg Med 2006; 30: 17–19
   PubMed Web of Science ®Google Scholar
• Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. Int Clin Psychopharmacol 2005; 20: 131–137
   PubMed Web of Science ®Google Scholar
• Nirmalani A, Stock SL, Catalano G. Syndrome of inappropriate antidiuretic hormone associated with escitalopram therapy. CNS Spectr 2006; 11: 429–432
   PubMed Web of Science ®Google Scholar
• Owens MJ, Rosenbaum JF. Escitalopram: a second-generation SSRI. CNS Spectr 2002; 7(Suppl 1)34–39
   PubMed Web of Science ®Google Scholar
• Remick RA, Froeze C, Keller FD. Common side effects associated with monoamine oxidase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13: 497–504
   PubMed Web of Science ®Google Scholar
• Wade A, Despiegel N, Reines EH. Escitalopram in the long-term treatment of major depressive disorder. Ann Clin Psychiatry 2006; 18: 83–89
   PubMedGoogle Scholar
• Yuksel FV, Tuzer V, Goka E. Escitalopram intoxication. Eur Psychiatry 2005; 20: 82–84
   PubMed Web of Science ®Google Scholar
• Zelefsky JR, Fine HF, Rubinstein VJ, Hsu IS, Finger PT. Escitalopram-induced uveal effusions and bilateral angle closure glaucoma. Am J Opthalmol 2006; 141: 1144–1147
   PubMed Web of Science ®Google Scholar